{"id":"W2947511888","doi":"10.1200/jco.2019.37.15_suppl.4030","title":"A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Capecitabine; Tolerability; Immunogenicity; HER2/neu; Internal medicine; Trastuzumab; Cancer; Oncology; Peptide vaccine; Chemotherapy; Gastroenterology; Breast cancer; Adjuvant; Antibody; Immunology; Epitope; Adverse effect; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001291477,0.00154926,0.002095597,0.0005301792,0.0004061415,0.0007514441,0.0009583813,0.001166089,0.002256108],"category_scores_gemma":[0.000659708,0.0007175075,0.0008767244,0.0004859287,0.001098252,0.0008724901,0.0003632464,0.002576463,0.0006507855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007782076,"about_ca_system_score_gemma":0.001650361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001134558,"about_ca_topic_score_gemma":0.001764436,"domain_scores_codex":[0.9996006,0.0001707834,0.00001902313,0.00006815044,0.00002886838,0.0001125639],"domain_scores_gemma":[0.9994888,0.00007995932,0.00007510681,0.00004531544,0.0000310323,0.000279801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6067671,0.2071921,0.006276338,0.001167907,0.0009882809,0.0004730707,0.0006307221,0.00542082,0.08786971,0.0004741477,0.002853042,0.07988667],"study_design_scores_gemma":[0.2514803,0.7370766,0.004644021,0.0000204539,0.0001891452,0.0001386982,0.00004321234,0.0009207224,0.004173075,0.0001053864,0.001191094,0.00001727053],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932905,0.0009491099,0.0004734544,0.0002265556,0.0001331503,0.003157998,0.000408872,0.00007244454,0.001287895],"genre_scores_gemma":[0.9919297,0.001070447,0.001295614,0.0004236535,0.0001310466,0.002836409,0.0009445278,0.00001956943,0.001349039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002256108,"threshold_uncertainty_score":0.007547379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07432630902825714,"score_gpt":0.4537691023314801,"score_spread":0.3794427933032229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}